Skip to main content
CriticalFDAfda-F-1090-2016OTHER

Wild Mushroom Soup packaged in a 24 oz clear plastic container with green and white label and green lettering.

⚠ Critical Alert — Stop Using Immediately

This product has been flagged with severe risks (other). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.

Category
Units Affected
33
Recall Date
November 9, 2015
Issuing Agency
Hazard
Other

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1090-2016.

The Wild Mushroom soup was MIS-la bled and does not declare chestnuts.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1090-2016.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Brett Anthony Foods or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1090-2016.

Brett Anthony Foods

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Brett Anthony Foods Recall FAQ

Brett Anthony Foods is the subject of a food safety report: Wild Mushroom Soup packaged in a 24 oz clear plastic container with green and white label and green lettering.. The notice was published on November 9, 2015 by the U.S. Food and Drug Administration (FDA). Approximately 33 units are potentially affected.